Senti Biosciences Inc (NASDAQ: SNTI) on Tuesday, plunged -35.56% from the previous trading day, before settling in for the closing price of $2.39. Within the past 52 weeks, SNTI’s price has moved between $1.26 and $7.10.
The company achieved an average annual earnings per share of 78.01%. With a float of $6.70 million, this company’s outstanding shares have now reached $26.29 million.
Senti Biosciences Inc (SNTI) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Senti Biosciences Inc is 74.53%, while institutional ownership is 6.98%. The most recent insider transaction that took place on Feb 04 ’25, was worth 15,963. In this transaction CEO of this company sold 3,922 shares at a rate of $4.07, taking the stock ownership to the 82,627 shares. Before that another transaction happened on Feb 06 ’25, when Company’s CEO sold 545 for $4.36, making the entire transaction worth $2,376. This insider now owns 82,082 shares in total.
Senti Biosciences Inc (SNTI) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.67 earnings per share (EPS) for the period topping the consensus outlook (set at -3.13) by 2.46. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 78.01% per share during the next fiscal year.
Senti Biosciences Inc (NASDAQ: SNTI) Trading Performance Indicators
Senti Biosciences Inc (SNTI) is currently performing well based on its current performance indicators. A quick ratio of 1.51 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.34, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.41 in one year’s time.
Technical Analysis of Senti Biosciences Inc (SNTI)
Senti Biosciences Inc (NASDAQ: SNTI) saw its 5-day average volume 14.82 million, a positive change from its year-to-date volume of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 47.99%.
During the past 100 days, Senti Biosciences Inc’s (SNTI) raw stochastic average was set at 17.28%, which indicates a significant increase from 1.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.26 in the past 14 days, which was higher than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.93, while its 200-day Moving Average is $2.42. Nevertheless, the first resistance level for the watch stands at $2.44 in the near term. At $3.34, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.81. If the price goes on to break the first support level at $1.08, it is likely to go to the next support level at $0.61.
Senti Biosciences Inc (NASDAQ: SNTI) Key Stats
Market capitalization of the company is 40.49 million based on 26,291K outstanding shares. Right now, sales total 0 K and income totals -52,790 K. The company made 0 K in profit during its latest quarter, and -18,130 K in sales during its previous quarter.
